Meregalli, C., Bonomo, R., Cavaletti, G., & Carozzi, V. (2021). Blood molecular biomarkers for chemotherapy-induced peripheral neuropathy: From preclinical models to clinical practice. NEUROSCIENCE LETTERS, 749(1 April 2021) [10.1016/j.neulet.2021.135739].

Carozzi, V., Bolino, A., D'Antonio, M., Quattrini, A., & Cavaletti, G. (2021). Nerve pathology in animal models of neuropathies. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM [10.1111/jns.12463].

Meregalli, C., Maricich, Y., Cavaletti, G., Canta, A., Carozzi, V., Chiorazzi, A., et al. (2021). Reversal of bortezomib-induced neurotoxicity by suvecaltamide, a selective T-type ca-channel modulator, in preclinical models. CANCERS, 13(19) [10.3390/cancers13195013].

Meregalli, C., Fumagalli, G., Alberti, P., Canta, A., Chiorazzi, A., Monza, L., et al. (2020). Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity. ARCHIVES OF TOXICOLOGY, 94(7), 2517-2522 [10.1007/s00204-020-02755-w].

Canta, A., Chiorazzi, A., Pozzi, E., Fumagalli, G., Monza, L., Meregalli, C., et al. (2020). Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity. ANTIOXIDANTS, 9(7), 1-11.